Cargando…

Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is one of the fatal tumors and is associated with a poor prognosis. Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was used to quantify the proportions of 22 types of immune cells. Weighted gene co-expression network analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Binglin, Xie, Xiaowei, Lan, Feifeng, Liu, Wenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806742/
https://www.ncbi.nlm.nih.gov/pubmed/34369264
http://dx.doi.org/10.1080/21655979.2021.1960764
_version_ 1784643526295814144
author Chen, Binglin
Xie, Xiaowei
Lan, Feifeng
Liu, Wenqi
author_facet Chen, Binglin
Xie, Xiaowei
Lan, Feifeng
Liu, Wenqi
author_sort Chen, Binglin
collection PubMed
description Non-small cell lung cancer (NSCLC) is one of the fatal tumors and is associated with a poor prognosis. Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was used to quantify the proportions of 22 types of immune cells. Weighted gene co-expression network analysis (WGCNA) was established from the GSE37745 data, and key modules correlating most with CD8(+) T cell infiltration were determined. Genes that manifested a high module connectivity in the key module were identified as hub genes. Three bioinformatics online databases were used to evaluate hub gene expression levels in tumor and normal tissues. Finally, survival analysis was conducted for these hub genes. In this study, we chose four hub genes (AURKB, CDC20, TPX2 and KIF2C) based on the comprehensive bioinformatics analyses. All hub genes were overexpressed in tumor tissue, and high expression of AURKB, CDC20, TPX2, and KIF2C correlated with the poor prognosis of these patients. In vitro experiments confirmed that CDC20 knockdown inhibited cell proliferation and growth. The above results indicated that AURKB, CDC20, TPX2, and KIF2C are potential CD8(+) T cell infiltration-related biomarkers and therapeutic targets.
format Online
Article
Text
id pubmed-8806742
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88067422022-02-02 Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer Chen, Binglin Xie, Xiaowei Lan, Feifeng Liu, Wenqi Bioengineered Research Paper Non-small cell lung cancer (NSCLC) is one of the fatal tumors and is associated with a poor prognosis. Cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was used to quantify the proportions of 22 types of immune cells. Weighted gene co-expression network analysis (WGCNA) was established from the GSE37745 data, and key modules correlating most with CD8(+) T cell infiltration were determined. Genes that manifested a high module connectivity in the key module were identified as hub genes. Three bioinformatics online databases were used to evaluate hub gene expression levels in tumor and normal tissues. Finally, survival analysis was conducted for these hub genes. In this study, we chose four hub genes (AURKB, CDC20, TPX2 and KIF2C) based on the comprehensive bioinformatics analyses. All hub genes were overexpressed in tumor tissue, and high expression of AURKB, CDC20, TPX2, and KIF2C correlated with the poor prognosis of these patients. In vitro experiments confirmed that CDC20 knockdown inhibited cell proliferation and growth. The above results indicated that AURKB, CDC20, TPX2, and KIF2C are potential CD8(+) T cell infiltration-related biomarkers and therapeutic targets. Taylor & Francis 2021-08-08 /pmc/articles/PMC8806742/ /pubmed/34369264 http://dx.doi.org/10.1080/21655979.2021.1960764 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Chen, Binglin
Xie, Xiaowei
Lan, Feifeng
Liu, Wenqi
Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
title Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
title_full Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
title_fullStr Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
title_full_unstemmed Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
title_short Identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
title_sort identification of prognostic markers by weighted gene co‐expression network analysis in non-small cell lung cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806742/
https://www.ncbi.nlm.nih.gov/pubmed/34369264
http://dx.doi.org/10.1080/21655979.2021.1960764
work_keys_str_mv AT chenbinglin identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer
AT xiexiaowei identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer
AT lanfeifeng identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer
AT liuwenqi identificationofprognosticmarkersbyweightedgenecoexpressionnetworkanalysisinnonsmallcelllungcancer